• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病心肌病:定义、诊断和治疗意义。

Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.

机构信息

IRCCS SDN, Via Gianturco 113, Naples 80142, Italy.

Department of Advanced Biomedical Sciences, Section of Cardiology, Federico II University of Naples, Via Sergio Pansini, 5, Naples 80131, Italy; Center for Congenital Heart Disease, University Hospital Inselspital, University of Bern, Freiburrgstrasse 18, Bern 3010, Switzerland.

出版信息

Heart Fail Clin. 2019 Jul;15(3):341-347. doi: 10.1016/j.hfc.2019.02.003. Epub 2019 Apr 5.

DOI:10.1016/j.hfc.2019.02.003
PMID:31079692
Abstract

A strict bidirectional relationship exists between diabetes mellitus and heart failure. Diabetic cardiomyopathy is a specific cardiac manifestation of patients with diabetes characterized by left ventricular hypertrophy and diastolic dysfunction in the early phase up to overt heart failure with reduced systolic function in the advanced stages. The pathogenesis of this condition is multifactorial and recognizes as main promoting factors the presence of insulin resistance and hyperglycemia. Diabetic cardiomyopathy exerts a negative prognostic impact in affected patients and no target treatments are currently available. More efforts are needed to better define the diagnostic and therapeutic approach in this specific setting.

摘要

糖尿病和心力衰竭之间存在严格的双向关系。糖尿病心肌病是糖尿病患者的一种特定心脏表现,其特征为早期左心室肥厚和舒张功能障碍,晚期出现收缩功能降低的心力衰竭。这种疾病的发病机制是多因素的,主要促进因素为胰岛素抵抗和高血糖的存在。糖尿病心肌病对受影响的患者产生负面影响,目前尚无针对该疾病的特效治疗方法。需要进一步努力以更好地定义该特殊情况下的诊断和治疗方法。

相似文献

1
Diabetic Cardiomyopathy: Definition, Diagnosis, and Therapeutic Implications.糖尿病心肌病:定义、诊断和治疗意义。
Heart Fail Clin. 2019 Jul;15(3):341-347. doi: 10.1016/j.hfc.2019.02.003. Epub 2019 Apr 5.
2
Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies.临床方法治疗糖尿病性心肌病:人类研究综述。
Curr Med Chem. 2018;25(13):1510-1524. doi: 10.2174/0929867324666170705111356.
3
Diabetic cardiomyopathy.糖尿病性心肌病。
Rev Clin Esp (Barc). 2022 Feb;222(2):100-111. doi: 10.1016/j.rceng.2019.10.012. Epub 2020 Oct 23.
4
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes.临床糖尿病性心肌病:一种具有限制型和扩张型表型的两面性疾病。
Eur Heart J. 2015 Jul 14;36(27):1718-27, 1727a-1727c. doi: 10.1093/eurheartj/ehv134. Epub 2015 Apr 17.
5
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.潜在机制对糖尿病性心肌病的识别和管理的影响。
J Am Coll Cardiol. 2018 Jan 23;71(3):339-351. doi: 10.1016/j.jacc.2017.11.019.
6
Diabetic cardiomyopathy: ongoing controversies in 2012.糖尿病性心肌病:2012年仍存的争议
Herz. 2012 Dec;37(8):880-6. doi: 10.1007/s00059-012-3720-z.
7
Pathogenesis, Clinical Features and Treatment of Diabetic Cardiomyopathy.糖尿病心肌病的发病机制、临床特征及治疗。
Adv Exp Med Biol. 2018;1067:197-217. doi: 10.1007/5584_2017_105.
8
Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.糖尿病与慢性心力衰竭:从糖尿病性心肌病到治疗方法
Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):38-50. doi: 10.2174/1871530311313010006.
9
Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.在体内糖尿病小鼠模型中,长期给予硝酰基供体1-亚硝基环己基乙酸酯可限制左心室舒张功能障碍。
Circ Heart Fail. 2015 May;8(3):572-81. doi: 10.1161/CIRCHEARTFAILURE.114.001699. Epub 2015 Mar 3.
10
Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.糖尿病性心肌病:射血分数保留的B期心力衰竭的一种表现。
Diab Vasc Dis Res. 2015 Jul;12(4):234-8. doi: 10.1177/1479164115579006. Epub 2015 Apr 23.

引用本文的文献

1
Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease.2型糖尿病无明显心血管疾病患者的左心室射血分数储备及其与心肌灌注、冠状动脉钙化和应变的关系。
Cardiovasc Diabetol. 2025 Aug 31;24(1):352. doi: 10.1186/s12933-025-02886-3.
2
Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathy.人类糖尿病缺血性心肌病的左心室心肌分子特征
EMBO Mol Med. 2025 Aug 4. doi: 10.1038/s44321-025-00281-9.
3
Mechanisms and therapeutics of insulin signaling transduction genes in diabetic cardiomyopathy: a comprehensive updated review.
糖尿病性心肌病中胰岛素信号转导基因的机制与治疗:全面更新综述
Front Endocrinol (Lausanne). 2025 Jul 17;16:1589695. doi: 10.3389/fendo.2025.1589695. eCollection 2025.
4
Sea buckthorn flavonoids and their derivatives: potential natural compounds for the treatment of diabetic cardiomyopathy.沙棘黄酮及其衍生物:治疗糖尿病性心肌病的潜在天然化合物。
Front Pharmacol. 2025 Jul 17;16:1599756. doi: 10.3389/fphar.2025.1599756. eCollection 2025.
5
Cardiac digital twins: a tool to investigate the function and treatment of the diabetic heart.心脏数字孪生体:一种用于研究糖尿病性心脏功能与治疗的工具。
Cardiovasc Diabetol. 2025 Jul 18;24(1):293. doi: 10.1186/s12933-025-02839-w.
6
Deciphering the role of crucial miRNAs involved in diabetic cardiomyopathy through a multiomics approach.通过多组学方法解析关键微小RNA在糖尿病性心肌病中的作用。
Sci Rep. 2025 Jul 8;15(1):24456. doi: 10.1038/s41598-025-09084-x.
7
Evaluation of the Effects of the Sodium-Glucose Cotransporter 2 Inhibitors and Sacubitril/Valsartan Combined Therapy in Patients with HFrEF: An Echocardiographic Study.钠-葡萄糖协同转运蛋白2抑制剂与沙库巴曲缬沙坦联合治疗对射血分数降低的心力衰竭患者的影响评估:一项超声心动图研究
Int J Mol Sci. 2025 Jun 12;26(12):5651. doi: 10.3390/ijms26125651.
8
Trapidil attenuates diabetic cardiomyopathy via GPX3/Nrf2-mediated inhibition of myocardial pyroptosis.曲匹地尔通过GPX3/Nrf2介导的对心肌细胞焦亡的抑制作用减轻糖尿病心肌病。
Front Pharmacol. 2025 Jun 3;16:1566622. doi: 10.3389/fphar.2025.1566622. eCollection 2025.
9
Unlocking the therapeutic potential of lncRNA FENDRR in DCM: novel targets and insights via the miR-296-5p/HMGA1 axis.解锁长链非编码RNA FENDRR在扩张型心肌病中的治疗潜力:通过miR-296-5p/HMGA1轴的新靶点及见解
J Cardiothorac Surg. 2025 May 31;20(1):254. doi: 10.1186/s13019-025-03477-9.
10
The impact of diabetes duration and glycemic control on ejection fraction in heart failure patients.糖尿病病程和血糖控制对心力衰竭患者射血分数的影响。
Acta Diabetol. 2025 May 7. doi: 10.1007/s00592-025-02519-x.